[{"arm_notes": "", "treatment_id": null, "treatment_name": "Vaccine candidate CIGB-66 (RBD 50 \u00b5g + Aluminum hydroxide 0;30 mg)/0;5 mL by intramuscular route; in the deltoid regi\u00f3n; schedule 0-14-28 days.;Immunogenicity; Vaccine ;Immunotherapy; Active ;Vaccination;Injections; Intramuscular ;CIGB-66", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1975, "treatment_name": "Cigb-66", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Vaccine candidate CIGB-66 (RBD 50 ug + Aluminum hydroxide 0;30 mg)/0;5 mL by intramuscular route; in the deltoid regi?n; schedule 0-14-28 days.;Immunogenicity; Vaccine;CIGB-66", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]